Several genetic alterations affecting components of the NF-κB pathway have been described in CLL, and persistent BCR signaling provides continuous activation cues for this pathway [17,18,19,20]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.